Investor mix
7 investors on record; lead investors include Connecticut Innovations, Elm Street Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |
Operates a recombinant antibody discovery and development services platform
7 investors on record; lead investors include Connecticut Innovations, Elm Street Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |